Expert consensus on immunoprophylaxis of cervical cancer and other human papillomavirus- related diseases (2025 edition).
10.3760/cma.j.cn112338-20250530-00364
- Collective Name:Chinese Preventive Medicine Association;Vaccine and Immunization Branch, Chinese Preventive Medicine Association
- Publication Type:Consensus Development Conference
- MeSH:
Humans;
Uterine Cervical Neoplasms/virology*;
Papillomavirus Vaccines/therapeutic use*;
Papillomavirus Infections/prevention & control*;
Female;
Consensus;
Papillomaviridae/immunology*;
Vaccination;
Human Papillomavirus Viruses
- From:
Chinese Journal of Epidemiology
2025;46(7):1107-1141
- CountryChina
- Language:Chinese
-
Abstract:
There have been recent, significant changes in strategies and policies for elimination of cervical cancer and advances in research of human papillomavirus (HPV)-related diseases and their prevention and control. Based on the latest national and international research, and building on a consensus published in 2019, we developed an expert consensus on immunoprophylaxis of cervical cancer and other human papillomavirus-related diseases (2025 edition) in order to provide clinicians, disease prevention and control professionals, and vaccination staff a reference for the prevention and control of cervical cancer and other HPV-related diseases and systematic, comprehensive evidence-based support for the scientific use of HPV vaccines to optimize their prevention effectiveness.
